F. Herting

Non-Clinical Pharmacokinetic/Pharmacodynamic and Early Clinical Studies Supporting Development of a Novel Subcutaneous Formulation for the Monoclonal Antibody Rituximab

F. Hourcade‐Potelleret, B. Bittner, W. Richter, 2014, Drug Research.

Development of a Subcutaneous Formulation for Trastuzumab – Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen

F. Hourcade‐Potelleret, B. Bittner, W. Richter, 2012, Arzneimittelforschung/Drug Research.